Inhibition the signal pathway by silence RIPK3 or suppresses the activity of RIPK3 may abolish inflammatory responses which is critical in modulating tumor initiation and progression (Seifert et al., 2016; Jayakumar and Bothwell, 2019). The gene discussed is RIPK3; the disease is neoplasm.